The group of researchers were the first to take snapshots of the moment naloxone reverses an opioid overdose in the brain.

While the FDA has classified synthetic kratom as a public health threat and dozens of states have enacted regulations or bans ...

Chronic pain is a daily reality for millions of Americans, interfering with their everyday activities and quality of life. An ...

A proposal to ban the sale of a powerful synthetic compound derived from the kratom plant advanced at Rockford City Council ...

Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological ...

Yichang Humanwell Pharmaceutical Co. Ltd. has disclosed morphinan derivatives acting as κ-opioid receptor agonists reported to be useful for the treatment of pain and pruritus.

The RespireRx Group holds exclusive licenses and owns patents and patent applications or rights thereto for certain families of chemical compounds that claim the chemical structures and their uses in ...

The move follows The Star’s recent investigation of the KC company and its sales of 7-OH, an addictive kratom extract.

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...

The implantation of electrodes in a patient with obesity has allowed the detection of the trace of tirzepatide in the nucleus ...

RespireRx Pharmaceuticals Inc. ('RespireRx” or the 'Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...